Ireland
--:--IST
Recruiting Observational

Reconstructions of Chest Wall Defects: a Retrospective Study

NCT06774755 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2023-08-02
Last updated
2025-01-14

Condition(s) studied

Chest Wall Deformity

Study summary

Patients requiring thoracic reconstruction often suffer from numerous comorbidities, such as obesity, diabetes, atherosclerosis and cardiovascular diseases, respiratory diseases. The clinical picture of these patients must be carefully stabilized in the preoperative period since the listed diseases are associated with a poor reconstructive outcome. Furthermore, it is necessary to preoperatively determine the spirometric characteristics in cases where the intervention may alter the respiratory dynamics to evaluate the patient's ability to tolerate the procedure. The primary objective of the study is to identify the best diagnostic-therapeutic approach in cases of complex chest wall defects, retrospectively evaluating the outcomes and therapeutic choices implemented, through a reassessment of the interventions performed and the clinical progress of patients undergoing complex thoracic and sternal reconstruction interventions managed in a multidisciplinary and non-multidisciplinary manner

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * All patients undergoing sternal or thoracic reconstruction in collaboration or not with the Reconstructive Plastic Surgery Unit * Obtaining informed consent Exclusion Criteria: \-

Primary outcome measure(s)

  • Technical Success — From the first patient enrolled, up to the 100th patient
    Thechnical success is evaluated by duration of surgery, complications and need for reoperation, and hospitalization time

Trial sites (1)

FacilityCityRegionStatus
IRCCS AOU di Bologna Policlinico di Sant'Orsola Bologna Italy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06774755 on ClinicalTrials.gov ↗ ← All trials in Italy